Pila Pharma AB (publ) (PILA.ST)

SEK 3.87

(5.16%)

Inventory Summary of Pila Pharma AB (publ)

  • Pila Pharma AB (publ)'s latest annual inventory in 2023 was 1.00 SEK , up 100.0% from previous year.
  • Pila Pharma AB (publ)'s latest quarterly inventory in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • Pila Pharma AB (publ) reported annual inventory of -347.08 Thousand SEK in 2022, down -20.42% from previous year.
  • Pila Pharma AB (publ) reported annual inventory of -288.23 Thousand SEK in 2021, down -127.01% from previous year.
  • Pila Pharma AB (publ) reported quarterly inventory of - SEK for 2024 Q2, down 0.0% from previous quarter.
  • Pila Pharma AB (publ) reported quarterly inventory of 1.00 SEK for 2023 Q4, up 100.0% from previous quarter.

Annual Inventory Chart of Pila Pharma AB (publ) (2023 - 2015)

Historical Annual Inventory of Pila Pharma AB (publ) (2023 - 2015)

Year Inventory Inventory Growth
2023 1.00 SEK 100.0%
2022 -347.08 Thousand SEK -20.42%
2021 -288.23 Thousand SEK -127.01%
2020 -126.97 Thousand SEK 75.74%
2019 -523.42 Thousand SEK 2.44%
2018 -536.52 Thousand SEK 5.25%
2017 -566.26 Thousand SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%

Peer Inventory Comparison of Pila Pharma AB (publ)

Name Inventory Inventory Difference
Alligator Bioscience AB (publ) 2.00 SEK 50.0%
Ziccum AB (publ) -4.18 Million SEK 100.0%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) -7.13 Million SEK 100.0%
Mendus AB (publ) - SEK -Infinity%
Genovis AB (publ.) 14.9 Million SEK 100.0%
Intervacc AB (publ) 10.48 Million SEK 100.0%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Active Biotech AB (publ) -2500.00 SEK 100.04%
Magle Chemoswed Holding AB (publ) 35.22 Million SEK 100.0%
Bio-Works Technologies AB (publ) 9.06 Million SEK 100.0%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) -1950.00 SEK 100.051%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) 3.15 Million SEK 100.0%
Saniona AB (publ) 1.00 SEK 0.0%
Lipigon Pharmaceuticals AB (publ) -1.62 Million SEK 100.0%
Biovica International AB (publ) 2.19 Million SEK 100.0%
Spago Nanomedical AB (publ) 1.00 SEK 0.0%
AcouSort AB (publ) 2.08 Million SEK 100.0%
Xintela AB (publ) 398 Thousand SEK 100.0%
Abliva AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 700 Thousand SEK 100.0%
Karolinska Development AB (publ) - SEK -Infinity%
OncoZenge AB (publ) -862.99 Thousand SEK 100.0%
Amniotics AB (publ) 534 Thousand SEK 100.0%
2cureX AB (publ) -1000.00 SEK 100.1%
CombiGene AB (publ) -1.79 Million SEK 100.0%
Asarina Pharma AB (publ) - SEK -Infinity%
Calliditas Therapeutics AB (publ) 20.42 Million SEK 100.0%
Camurus AB (publ) 100.95 Million SEK 100.0%
Corline Biomedical AB -3.85 Million SEK 100.0%
IRLAB Therapeutics AB (publ) 1000.00 SEK 99.9%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB 4.28 Million SEK 100.0%
Hansa Biopharma AB (publ) 9.79 Million SEK 100.0%
Cyxone AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) - SEK -Infinity%
Biosergen AB -4.92 Million SEK 100.0%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB 545.23 Thousand SEK 100.0%
Xspray Pharma AB (publ) 43.78 Million SEK 100.0%
Elicera Therapeutics AB (publ) -446.98 Thousand SEK 100.0%
Nanologica AB (publ) 2.97 Million SEK 100.0%
SynAct Pharma AB - SEK -Infinity%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) -321.14 Thousand SEK 100.0%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 11.84 Million SEK 100.0%
Alzinova AB (publ) -3.27 Million SEK 100.0%
Oncopeptides AB (publ) 2.42 Million SEK 100.0%
Guard Therapeutics International AB (publ) -1486.00 SEK 100.067%
Scandinavian ChemoTech AB (publ) 4.03 Million SEK 100.0%
Simris Alg AB (publ) 1.09 Million SEK 100.0%
Diamyd Medical AB (publ) 24.05 Million SEK 100.0%
Xbrane Biopharma AB (publ) 106.85 Million SEK 100.0%
Ascelia Pharma AB (publ) - SEK -Infinity%
Diagonal Bio AB (publ) 1.02 Million SEK 100.0%